Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2

Journal of Pathology

Volumn 217, Issue 4, 2009, Pages 571-580

  Reiss, Yvonne ^a   Knedla, Anette ^a,f   Tal, Andrea O ^a   Schmidt, Mirko H H ^a   Jugold, Manfred ^b   Kiessling, Fabian ^b,g   Burger, Angelika M ^c   Wolburg, Hartwig ^d   Deutsch, Urban ^e   Plate, Karl H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

^g RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Angiopoietin; Neoplasia; Tie2; Tumour growth; Vessel morphology

Indexed keywords

ANGIOPOIETIN 2; ANGIOTENSIN I; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER MORPHOLOGY; CARCINOGENESIS; CELL LOSS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE SWITCHING; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR BLEEDING; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION; XENOGRAFT;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CELL LINE, TUMOR; ENDOTHELIAL CELLS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PHENOTYPE; RECEPTOR, TIE-2; TRANSPLANTATION, HETEROLOGOUS;

EID: 62849096084     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2484     Document Type: Article

References (46)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995;1:27-31.
3. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
4. Holash J, Maisonpierre PC, Compton D, Boland P, Alexan der CR, Zagzag D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-1998.
5. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
6. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Old mixon EH, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
7. Peters KG. Vascular endothelial growth factor and the angiopoi etins: working together to build a better blood vessel. Circ Res 1998;83:342-343.
8. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovasculariza tion. Circ Res 1998;83:233- 240.
9. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998;273:18514-18521.
10. Kwak HJ, So JN, Lee SJ, Kim I, Koh GY. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 1999;448:249-253.
11. Stratmann A, Risau W, Plate KH. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998;153:1459-1466.
12. Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wie gand SJ, et al. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 1999;159:391-400.
13. Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 1999;103:341-345.
14. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 1999;6:7-22.
15. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-1380.
16. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDon ald DM. Abnormalities in pericytes on blood vessels and endothe lial sprouts in tumors. Am J Pathol 2002;160:985-1000.
17. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonen dothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 2003;112:1142-1151.
18. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nature Cell Biol 2008;10:527-537.
19. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nature Cell Biol 2008;10:513-526.
20. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 2001;61:2145- 2153.
21. Machein MR, Knedla A, Knoth R, Wagner S, Neuschl E, Plate KH. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol 2004;165:1557-1570.
22. Yu Q, Stamenkovic I. Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol 2001;158:563-570.
23. Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, et al. Tumor-derived vascular endothelial growth factor upregulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 2003;63:3403-3412.
24. Tian S, Hayes AJ, Metheny-Barlow LJ, Li LY. Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br J Cancer 2002;86:645-651.
25. Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Parikh AA, Fan F, et al. Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. Br J Cancer 2002;87:1182-1187.
26. Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Wey JS, Parikh AA, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res 2003;63:3370-3377.
27. Shim WS, Teh M, Bapna A, Kim I, Koh GY, Mack PO, et al. Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice. Exp Cell Res 2002;279:299-309.
28. Oliner J, Min H, Leal J, Yu D, Rao S, You E, et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell. 2004;6:507-516.
29. Reiss Y, Machein MR, Plate KH. The role of angiopoietins during angiogenesis in gliomas. Brain Pathol 2005;15:311-317.
30. Stratmann A, Acker T, Burger AM, Amann K, Risau W, Plate KH. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants. Int J Cancer 2001;91:273-282.
31. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcrip tion in eukaryotes: novel transactivators with graded transactiva tion potential. Nucleic Acids Res 1997;25:2723-2729.
32. Schmidt MH, Hoeller D, Yu J, Furnari FB, Cavenee WK, Dikic I, et al. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol 2004;24:8981-8993.
33. Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 2008;453:410-414.
34. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628.
35. Cao Y, Sonveaux P, Liu S, Zhao Y, Mi J, Clary BM, et al. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res 2007;67:3835- 3844.
36. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, et al. Angiopoietin-1 is an antipermeability and antiinflammatory agent in vitro and targets cell junctions. Circ Res 2000;87:603-607.
37. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, et al. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002;10:1619-1628.
38. Hori S, Ohtsuki S, Hosoya K, Nakashima E, Terasaki T. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem 2004;89:503-513.
39. Sundberg C, Kowanetz M, Brown LF, Detmar M, Dvorak HF. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 2002;82:387-401.
40. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999;18:5356-5362.
41. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF- dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 2002;99:11205-11210.
42. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
43. Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004;165:35-52.
44. Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, et al. Kinetics of vascular normalization by VEGFR2 block ade governs brain tumor response to radiation: role of oxygena tion, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004;6:553-563.
45. Nehls V, Drenckhahn D. A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro. Histochem Cell Biol 1995;104:459-466.
46. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998;8:529-532.